Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ImmunoPrecise Antibodies (TSE:IPA)
TSXV:IPA
RESEARCH TOOLSreports
ImmunoPrecise Antibodies (IPA) Stock Price & Analysis
23 Followers
IPA Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week Range― - ―
Previous CloseC$0
Volume0.00
Average Volume (3M)N/A
Market Cap
$89.31M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Oct 03, 2023EPS Estimate
-C$0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding25,050,260
10 Day Avg. Volume15,632
30 Day Avg. Volume17,417
Standard Deviation0.26
R-Squared0.00258
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)28.84
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$12.08Price Target Upside― Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
ImmunoPrecise Antibodies News
IPA FAQ
What was ImmunoPrecise Antibodies’s price range in the past 12 months?
Currently, no data Available
What is ImmunoPrecise Antibodies’s market cap?
Currently, no data Available
When is ImmunoPrecise Antibodies’s upcoming earnings report date?
ImmunoPrecise Antibodies’s upcoming earnings report date is Oct 03, 2023 which is 215 days ago.
How were ImmunoPrecise Antibodies’s earnings last quarter?
ImmunoPrecise Antibodies released its earnings results on Jul 07, 2023. The company reported -C$0.2 earnings per share for the quarter, missing the consensus estimate of -C$0.17 by -C$0.03.
Is ImmunoPrecise Antibodies overvalued?
According to Wall Street analysts ImmunoPrecise Antibodies’s price is currently Undervalued.
Does ImmunoPrecise Antibodies pay dividends?
ImmunoPrecise Antibodies does not currently pay dividends.
What is ImmunoPrecise Antibodies’s EPS estimate?
ImmunoPrecise Antibodies’s EPS estimate is -C$0.21.
How many shares outstanding does ImmunoPrecise Antibodies have?
Currently, no data Available
What happened to ImmunoPrecise Antibodies’s price movement after its last earnings report?
ImmunoPrecise Antibodies reported an EPS of -C$0.2 in its last earnings report, missing expectations of -C$0.17. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of ImmunoPrecise Antibodies?
Currently, no hedge funds are holding shares in TSE:IPA
---
ImmunoPrecise Antibodies Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$12.08 (― Upside)
C$12.08 (― Upside)
Insider Transactions
Bought Shares
Worth $2.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.41%
12-Months-Change
Fundamentals
Return on Equity
-39.57%
Trailing 12-Months
Asset Growth
-21.57%
Trailing 12-Months
Company Description
ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd. engages in the provision of integrated antibody solutions. It services include human monoclonals, hybridoma development, rabbit monoclonals, b-cell select, phage display, cryostorage, hybridoma sequencing, antibody generation, anti-body purification, polyclonal production, and peptide production. The company was founded by Robert Beecroft in 1989 and is headquartered in Victoria, Canada.
---
IPA Stock 12 Months Forecast
Average Price Target
―Aethlon Medical
―
Biocept
―
Lineage Therap
―
NovaBay Pharma
―
ImmunoPrecise Antibodies
―
Best Analysts Covering IPA
1 Year
1 Year Success Rate
0/3 ratings generated profit
1 Year Average Return
-22.17%
reiterated a buy rating a year ago
Copying Robert Wasserman's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -22.17% per trade.
---